Old Web
English
Sign In
Acemap
>
Paper
>
OP035 Efficacy and safety of abrilumab (AMG 181/MEDI 7183) therapy for moderate to severe Crohn's disease
OP035 Efficacy and safety of abrilumab (AMG 181/MEDI 7183) therapy for moderate to severe Crohn's disease
2017
William J. Sandborn
Marcoli Cyrille
M. Berner Hansen
Brian G. Feagan
Edward Vincent Loftus
Severine Vermeire
Martha L. Cruz
M. Mo
Barbara A. Sullivan
W. Reinisch
Keywords:
Physical therapy
Diabetes mellitus
Crohn's Disease Activity Index
Abrilumab
Inflammatory bowel disease
Medicine
Adverse effect
Randomization
Surrogate endpoint
Crohn's disease
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
17
Citations
NaN
KQI
[]